Claya Review

Claya in one line: more format choice, named names, but a few blanks left unfilled

Claya is a direct-to-consumer telehealth platform built around one genuinely useful idea: it sells compounded semaglutide and tirzepatide in both the usual weekly injection and a swallow-it oral tablet. That dual-format menu is wider than most compounded GLP-1 sellers offer, and Claya pairs it with something the category is usually shy about — it publishes the actual names of its prescribing clinicians and its two pharmacy partners. For a shopper who has spent any time on faceless compounding sites, that transparency is the headline reason to look here. The catch is that a handful of the trust details you would want before paying — which states it actually serves, its certification ID, and even what legal company you are buying from — are simply not on the site.

How Claya's pricing actually works (intro rate vs. the locked refill)

Claya runs a classic teaser structure. Injectable semaglutide starts at $179 for your first month, which is its cheapest door-in price and sits a little above the category median of $170. The thing to understand before you sign up is that the intro number does not last: refills lock in at just under three hundred dollars a month. So the real, ongoing cost of staying on injectable semaglutide is meaningfully higher than the figure on the homepage banner — the first month is a discount, not the rate. Oral tablets and tirzepatide each carry their own starting prices that step up from there. Claya frames the plan as all-in with no membership or hidden fees, and free expedited shipping is genuinely bundled into that monthly price.

One more wrinkle worth flagging: Claya also dangles a separate concierge 'membership' tier that costs vastly more — a four-figure monthly price aimed at a different buyer entirely. It is not the plan most people land on, and you should not confuse it with the standard medication price.

The medications — and the unusual oral-tablet option

On the injectable side, Claya offers compounded semaglutide and tirzepatide as a once-weekly shot, which is the same delivery method used by the brand-name versions and the form with the strongest evidence behind it. Where Claya breaks from the pack is the oral-tablet route for both molecules — a needle-free option that appeals to anyone squeamish about self-injection.

Be honest with yourself about the trade-off, though. Compounded oral GLP-1 tablets have considerably weaker efficacy data than injectable semaglutide; the gold-standard weight-loss trials were run on the injections, not on compounded pills. The oral format is a real convenience, but you may be paying a premium for less proven results. If maximum weight loss is the goal, the injection is the better-supported choice.

What genuinely sets Claya apart: it tells you who is behind the medicine

This is Claya's strongest card. Most compounded GLP-1 sites keep their clinicians and pharmacies anonymous. Claya names two licensed providers on its homepage — Jennifer Habashy, NMD, MS, and Dr. Michael Barber, MD, PhD — and it names both compounding pharmacy partners with full street addresses: RedRock Pharmacy in St. George, Utah, and Healthware House in Florence, Kentucky. That lets a motivated patient actually verify the supply chain instead of taking it on faith.

• Two named, licensed clinicians behind the prescriptions — rare in compounded GLP-1
• Two named pharmacy partners, each with a verifiable physical address
• Both injectable and oral-tablet forms for semaglutide and tirzepatide
• A weight-loss money-back guarantee published right on the homepage
• Free expedited shipping folded into the monthly price

Where Claya leaves you guessing

For all that openness, Claya withholds some basics. It does not publish the list of states it serves, so you only find out whether you qualify once you are deep in checkout. It does not display a LegitScript certification ID, a credential reputable telehealth pharmacies usually show off. And neither the site nor the privacy policy names the actual corporate legal entity you are contracting with — the privacy policy lists a Des Moines, Iowa, address and operations run out of Henderson, Nevada, but no LLC or Inc. behind the brand. None of these is a red flag on its own, but together they are the difference between a good-confidence verdict and a great one.

Who should choose Claya — and who should skip it

Choose Claya if you specifically want the oral-tablet option, or if clinician and pharmacy transparency is what has been holding you back from compounded GLP-1. The named providers, named pharmacies, and money-back guarantee make it an easier platform to trust than a typical anonymous compounder. Skip it if you need brand-name Wegovy or Zepbound (Claya is compounded-only), if you want the lowest sustained monthly cost (the locked refill rate undercuts the cheap first month), or if you will not proceed without seeing a LegitScript ID and a clearly disclosed states list up front.

Trust, safety, and our confidence level

We rate our verification confidence in Claya as medium. The positives are concrete and checkable: transparent pricing with no surprise membership fee, two named clinicians, and two named pharmacy partners with real addresses. The reservations are about disclosure, not about any FDA warning — there is none on file for Claya. What keeps it out of our top confidence tier is the missing states list, the absent LegitScript certification, and the undisclosed corporate entity. As with any compounded GLP-1, confirm the medication source and the prescribing clinician at checkout, and read how the money-back guarantee actually pays out before you rely on it. You can see how we weigh these factors in our scoring methodology.

Bottom line

Claya is one of the more transparent compounded GLP-1 platforms, and the oral-tablet option is a real differentiator for needle-averse patients. Just go in clear-eyed: the $179 headline is a first-month teaser that rises at refill, the oral tablets are less proven than the injections, and a few trust credentials are missing. For the right buyer — someone who values named clinicians and a needle-free choice over rock-bottom pricing — it earns a look.

If you're weighing alternatives, Sunlight ($159/month) and Bodybuilding Health+ ($179/month) are among the closest options we track to Claya.